Warning Letter Cites Inadequate Lab Controls at Illinois-based Lab
This article was originally published in The Gold Sheet
Warning letter was focused on Illinois firm’s lab controls.
You may also be interested in...
Drug makers win one-month reprieve for their nitrosamine risk assessments for new drug products and approved products.
Technologies like head-mounted tablets became critical for method transfers, virtual inspections and more. Cloud-based submissions could be next …
Post-approval change management protocols could go a long way toward smoothing global rollout of analytical method changes, ICH Q12 expert says.